![](https://stella-pharma.co.jp/en/wp/wp-content/themes/stella-pharma/shared/images/en/visual_2@2x.jpg)
![](https://stella-pharma.co.jp/en/wp/wp-content/themes/stella-pharma/shared/images/en/visual_sp_2.jpg)
STELLA PHARMA
NEWS
July 16th, 2024
Specified Clinical Research Contract concluded with Edogawa Hospital
― Providing our drug for Research on FDG-PET-positive shallow tumors ― Stell……
The paper “Efficacy and safety of boron neutron capture therapy for Hypopharyng……
June 24th, 2024
BNCT for Thoracic Malignant Tumor – Submission of Trial Plan Notification for Domestic Clinical Trial Phase I/II
We would like to announce that our company submitted the trial plan notificatio……
June 21st, 2024
Treatment results of unresectable, locally recurrent or locally advanced head and neck cancer published
A paper containing the treatment results of unresectable, locally recurrent or ……